CRSP
Price
$41.86
Change
+$3.29 (+8.53%)
Updated
Jun 6 closing price
Capitalization
3.33B
64 days until earnings call
SCPH
Price
$4.20
Change
+$0.09 (+2.19%)
Updated
Jun 6 closing price
Capitalization
216.98M
59 days until earnings call
Interact to see
Advertisement

CRSP vs SCPH

Header iconCRSP vs SCPH Comparison
Open Charts CRSP vs SCPHBanner chart's image
CRISPR Therapeutics AG
Price$41.86
Change+$3.29 (+8.53%)
Volume$4.73M
Capitalization3.33B
scPharmaceuticals
Price$4.20
Change+$0.09 (+2.19%)
Volume$424.76K
Capitalization216.98M
CRSP vs SCPH Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. SCPH commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and SCPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (CRSP: $37.22 vs. SCPH: $3.58)
Brand notoriety: CRSP and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 76% vs. SCPH: 58%
Market capitalization -- CRSP: $3.33B vs. SCPH: $216.98M
CRSP [@Biotechnology] is valued at $3.33B. SCPH’s [@Biotechnology] market capitalization is $216.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, SCPH is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while SCPH’s TA Score has 6 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 3 bearish.
  • SCPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CRSP and SCPH are a good buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а +0.64% price change this week, while SCPH (@Biotechnology) price change was +7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

SCPH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.33B) has a higher market cap than SCPH($217M). SCPH YTD gains are higher at: 1.130 vs. CRSP (-5.424). SCPH has higher annual earnings (EBITDA): -77.56M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. SCPH (75.7M). SCPH has less debt than CRSP: SCPH (52.7M) vs CRSP (224M). SCPH (36.3M) and CRSP (35M) have equivalent revenues.
CRSPSCPHCRSP / SCPH
Capitalization3.33B217M1,535%
EBITDA-447.31M-77.56M577%
Gain YTD-5.4241.130-480%
P/E RatioN/AN/A-
Revenue35M36.3M96%
Total Cash1.9B75.7M2,515%
Total Debt224M52.7M425%
FUNDAMENTALS RATINGS
CRSP vs SCPH: Fundamental Ratings
CRSP
SCPH
OUTLOOK RATING
1..100
718
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
8140
P/E GROWTH RATING
1..100
77100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (65) in the Biotechnology industry is in the same range as SCPH (67) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to SCPH’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SCPH (100) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to SCPH’s over the last 12 months.

CRSP's SMR Rating (94) in the Biotechnology industry is in the same range as SCPH (100) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to SCPH’s over the last 12 months.

SCPH's Price Growth Rating (40) in the Pharmaceuticals Major industry is somewhat better than the same rating for CRSP (81) in the Biotechnology industry. This means that SCPH’s stock grew somewhat faster than CRSP’s over the last 12 months.

CRSP's P/E Growth Rating (77) in the Biotechnology industry is in the same range as SCPH (100) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to SCPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPSCPH
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
89%
Momentum
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
85%
MACD
ODDS (%)
Bullish Trend 12 days ago
70%
Bullish Trend 12 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
81%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 12 days ago
76%
Declines
ODDS (%)
Bearish Trend 26 days ago
84%
Bearish Trend 26 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
83%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.92%
RXRX - CRSP
72%
Closely correlated
+0.11%
BEAM - CRSP
72%
Closely correlated
-0.88%
NTLA - CRSP
69%
Closely correlated
+3.59%
ABCL - CRSP
62%
Loosely correlated
+3.03%
ALLO - CRSP
61%
Loosely correlated
+5.56%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with AUTL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then AUTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
+1.13%
AUTL - SCPH
44%
Loosely correlated
+5.10%
AURA - SCPH
44%
Loosely correlated
+0.17%
CRSP - SCPH
43%
Loosely correlated
-0.92%
BEAM - SCPH
42%
Loosely correlated
-0.88%
IMNM - SCPH
41%
Loosely correlated
+0.35%
More